943320-51-2Relevant articles and documents
METHODS AND COMPOSITIONS FOR RAF KINASE MEDIATED DISEASES
-
Page/Page column 58, (2013/11/18)
The invention discloses methods and compositions for treating or preventing RAF kinase mediated diseases or conditions by administering a compound of Formula 1: or a pharmaceutically acceptable salt, solvate or hydrate thereof, wherein the variables are defined as herein.
BICYCLIC HETEROARYL COMPOUNDS
-
Page/Page column 55, (2008/06/13)
This invention relates to compounds of the general formula (I) in which the variable groups are as defined herein, and to their preparation and use.